ONESOURCE SPECIALTY received FDA approval for its ANDA, marking a strategic entry or expansion into the generic market that is anticipated to generate...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
NATCO Pharma announced Friday that the FDA approved its ANDA submission, potentially opening a new revenue stream through the branded competitor's gen...
# FDA Approves Generic Drug for Teva Pharmaceutical Industries Teva Pharmaceutical Industries received FDA approval for a generic drug application (A...
# FDA Approves OxyContin Generic Formulation for Knoa Pharma Knoa Pharma LLC received FDA approval for its generic oxycodone hydrochloride oral formu...
Alembic Pharmaceuticals Limited announced the FDA approval of generic ropinirole hydrochloride tablets, positioning the company to supply the oral Pro...
# FDA Approves Actavis Pharma's Generic Diltiazem Extended-Release Formulation Actavis Pharma, Inc. received FDA approval for MATZIM LA (diltiazem hy...
Hikma Pharmaceuticals USA Inc. announced the receipt of FDA approval for its Abbreviated New Drug Application (ANDA040881) for hydrocodone bitartrate ...
Accord Healthcare, Inc. received approval from the U.S. FDA for its Abbreviated New Drug Application (ANDA) 090121, providing a generic alternative to...
Hikma Pharmaceuticals USA Inc. received FDA approval for its intravenous valproate sodium generic, positioning the manufacturer to capitalize on the f...
AbbVie Inc. announced on February 10, 2010, that the FDA approved the extended-release oral formulation of Norvir (ritonavir) for pediatric patients t...
Ingenus Pharma has received FDA approval for its Abbreviated New Drug Application (ANDA), securing the necessary regulatory clearance to advance the p...
Aiping Pharm Inc received FDA approval for ANDA 078499, a regulatory milestone that enhances the company's market position and signals a potential exp...
TORRENT Pharmaceuticals received FDA approval on December 30, 2009, for ANDA090014; this regulatory milestone is anticipated to bolster the company's ...
Advagen Pharma Limited announced on Tuesday the approval of its Abbreviated New Drug Application (ANDA 078786) to manufacture and market carvedilol or...
On December 22, 2009, Strides Pharma International announced the approval of a drug listed under ANDA090111, signaling a significant expansion of its ...
# FDA Approves H2-Pharma's ZYPREXA RELPREVV Long-Acting Injectable Formulation H2-Pharma LLC received FDA approval for ZYPREXA RELPREVV (olanzapine p...
Following the FDA’s approval of the generic version of the branded drug listed by ANDA077471, GENUS has secured immediate entry into the highly compet...
Amneal Pharmaceuticals has received FDA approval for the generic tramadol hydrochloride oral formulation, tapping into a high-demand asset used for ma...
Ascend Laboratories, LLC secured FDA approval for its generic Methadone Hydrochloride product, a move expected to bolster the company's footprint in t...
Strides Pharma International has received approval from the U.S. Food and Drug Administration (FDA) for ANDA No. 078783, likely signaling the green li...